Confo Therapeutics is a drug discovery company based on disruptive technology to enable the discovery of G-protein-coupled receptors (GPCR) agonists. Its technology utilizes single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for drug discovery.